Implementation of Drug Administration Law

On:
In: Authoritative Interpretation, filing, Medicine/medical devices, NMPA
On November 29, the National medical products Administration-NMPA published notice on implementation of Drug Administration Law. Since December 1, 2019, the drug listing license holder system will be implemented. Any enterprise or drug development institution holding the drug registration certificate (drug approval number, imported drug registration certificate, medical product registration certificate) is the drug listing license holder, and is responsible for the safety, effectiveness and quality controllability of drugs in the whole process of drug development, production, operation and use. From December 1, 2019, the drug clinical trial institutions shall implement the filing management., The application accepted before December 1,Read More →

Thank you for your interests/registration! For complete and full access to our platform, please contact us to subscribe as a paid-up member. The annual fee is ＄5,500 Best! Paolo yue Email: yuefeng7832@hotmail.com Cell: 008613501397114

Existing Users Log In
   
New User Registration
*Required field

Related posts:

  1. Measures for the administration of drug registration 2020
  2. Drug Administration Law
  3. Measures for the Administration of Drug Recall
  4. Pharmacovigilance quality management specification
  5. Implementation of GMP for veterinary drug production 2020
  6. New Edition of Pharmaceutical License
  7. Interim Measures of Subsidy Funds for Food and Drug Administration
  8. Measures for registration and filing of medical devices
  9. NMPA issued 5 drug traceability standards
  10. Electronic registration certificate of medical devices